Skip to content

Cannabis: all studies

Page 212 of 288: studies 2,111 to 2,120 of 2,878, newest first. Back to the cannabis overview

Research

Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States: A National Study

Drug and Alcohol Review February 26, 2026 Katherine M Keyes, Yvonne Terry-Mcelrath, Megan E. Patrick

INTRODUCTION: This paper aimed to determine the prevalence, demographic correlates and co-occurring substance use patterns of hallucinogen microdosing among young adults in the United States. METHODS: Design: Cross-sectional analysis of data from a nationally-representative cohort study collected in 2022-2023. SETTING: United States. PARTICIPANTS: Sample of 3094 young adults aged 19-30 years in...

DOI: 10.1111/dar.70133 (opens in new tab) Young adult Context archaeology Epidemiology Drug +3

Cannabinoids

February 17, 2026 Linda A. Parker

The mysteries of the brain’s own cannabinoid system exposed and explained. Though cannabis has been used, for pain or pleasure, for over 4000 years, only lately have we learned, first, what makes it work and, more recently, how. Unraveling the mystery of the human brain’s special relationship with a psychoactive chemical derived from a plant—tetrahydrocannabinol, or THC,...

India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.

Indian Journal of Psychological Medicine February 5, 2026 Ashlyn Tom, B. Sai Chaitanya Reddy, Manik Inder Singh Sethi et al.

The “entourage effect,” well-documented in cannabis research, remains a hypothesis requiring validation in psilocybin mushrooms. Whether the complex interplay among multiple bioactive compounds (including psilocybin, psilocin, baeocystin, norbaeocystin, aeruginascin, and various alkaloids) produces synergistic effects distinct from those of isolated psilocybin remains a critical empirical...

Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review.

Psychiatry Research February 1, 2026 Valerio Ricci, Stefania Chiappini, Giovanni Martinotti et al.

BACKGROUND Novel psychoactive substances (NPS) represent an evolving public health threat, yet evidence on their acute and long-term psychiatric consequences remains limited. OBJECTIVE To systematically review psychiatric and neurological consequences of NPS use across the full clinical spectrum, with primary focus on synthetic cannabinoids and related compounds, and to characterize...

Administration of the Synthetic Cannabinoid WIN55,212-2 Increases BDNF Expression Levels in the Adolescent Rat Brain.

Cannabis and Cannabinoid Research February 1, 2026 Alejandro Guadalupe Torres, Jordan Santos, Dolores Vazquez Sanroman

The increase in cannabinoid use among adolescents has become a public health concern in North America, with more than one-third of 12th graders in the United States reporting consumption of some form of cannabis within the past year (2023).1,2 The use of cannabinoids during adolescence, a vulnerable stage for brain development, may alter the neuroplasticity dependent on brain-derived...

Burden of drugs and substance abuse among university students in Kenya

African journal of alcohol and drug abuse. January 22, 2026 Morris Kamenderi, John Muteti, Stephen Kimani et al.

Drugs and substance use among university students has been recognized as a global public health issue. Adolescents are particularly vulnerable to drugs and substance use (DSU) including addiction.This study sought to determine the burden of DSU among university students in Kenya. The study utilized a cross-sectional study design covering a representative sample of 17 public and private...

Drug Decriminalization and Recriminalization: Predicting the Future in Uncertain Times

Federal Sentencing Reporter January 22, 2026 Laura I. Appleman 1 citation

Abstract The shifting legal landscape of drug regulation in the United States has been marked by a growing divergence between state and federal approaches to cannabis and psychedelics. In recent years, numerous states have passed laws legalizing or decriminalizing marijuana and exploring the therapeutic potential of psychedelics, such as psilocybin and MDMA. At the same time, these trends are...

Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.

CNS Drugs January 17, 2026 Gaëlle Rached, Anna Campana, Dimitri Fiani et al. 1 citation

Monoamine oxidase inhibitors (MAOIs) remain an important option for patients with treatment-resistant depression (TRD) and other psychiatric conditions, despite potentially serious drug-drug interactions and associated dietary tyramine restrictions. However, they are rarely prescribed in patients with comorbid substance use disorders (SUDs) due to concerns about potential drug interactions and...

"I Couldn't Just Say 'Can You Go Home Please'": Exploring UK Adults' Freedom to Negotiate Alcohol- and Drug-Involved Sexual Experiences.

The Journal of Sex Research January 5, 2026 Lauren A Smith, Katerina Z Kolokotroni, Rhys Turner-Moore

There is limited research on how substance use impacts people's freedom to negotiate sexual activity with others, particularly in distinguishing between alcohol and drug use. This study addressed that gap by exploring how substance use can both extend and constrain sexual negotiation. A mixed-methods online survey of 354 UK adults aged 18-40 examined sexual consent across sober, alcohol-, and...

Clinical Characteristics of Health Professions Students with Nitrous Oxide Use Disorder.

Journal of Psychoactive Drugs 2026 Bernard Angerville, Alexandre Szusterman, Lisa Blecha et al.

Recreational use and misuse of nitrous oxide (N2O) have increased in recent years among young people. The objective of present study was to assess the frequency and the clinical characteristics of N2O use disorder (NUD) in a sample of health professions students. An online survey was distributed to health professions students. Age; sex; frequency (day/week/month/year/lifetime) of N2O use, DSM-5...